Canopy Growth (CGC) Common Equity (2017 - 2025)
Canopy Growth's (CGC) quarterly Common Equity came in at $543.7 million in Q4 2025, up 28.4% year-on-year from $423.4 million in Q4 2024, and up 1.66% quarter-over-quarter from $534.8 million in Q3 2025.
Canopy Growth (CGC) Common Equity (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Common Equity across 9 years of filings, most recently posting $543.7 million for Q4 2025.
- Common Equity for Q4 2025 came in at $543.7 million, up 28.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $543.7 million (up 28.4% YoY), and the FY2025 annual result was $339.5 million, down 8.58% from the prior year.
- Common Equity came in at $543.7 million for Q4 2025 at Canopy Growth, up from $534.8 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $3.4 billion in Q3 2021 to a low of $339.5 million in Q1 2025.
- The 5-year median for Common Equity is $560.6 million (2023), against an average of $1.2 billion.
- Across the five-year window, Common Equity sank 80.15% in 2023 and surged 43.15% in 2025, its largest moves.
- Canopy Growth's Common Equity stood at $3.3 billion in 2021, then tumbled by 69.6% to $998.1 million in 2022, then slumped by 59.92% to $400.1 million in 2023, then climbed by 5.83% to $423.4 million in 2024, then advanced by 28.4% to $543.7 million in 2025.
- The last three Common Equity figures came in at $543.7 million (Q4 2025), $534.8 million (Q3 2025), and $352.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 543.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 543.68 Mn |
| Sep 30, 2025 | 534.81 Mn |
| Jun 30, 2025 | 352.90 Mn |
| Mar 31, 2025 | 339.55 Mn |
| Dec 31, 2024 | 423.41 Mn |
| Sep 30, 2024 | 373.61 Mn |
| Jun 30, 2024 | 389.64 Mn |
| Mar 31, 2024 | 371.43 Mn |
| Dec 31, 2023 | 400.07 Mn |
| Sep 30, 2023 | 559.05 Mn |
| Jun 30, 2023 | 630.93 Mn |
| Mar 31, 2023 | 562.19 Mn |
| Dec 31, 2022 | 998.12 Mn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.29 Bn |
| Mar 31, 2022 | 2.83 Bn |
| Dec 31, 2021 | 3.28 Bn |
| Sep 30, 2021 | 3.37 Bn |
| Jun 30, 2021 | 3.37 Bn |
| Mar 31, 2021 | 2.75 Bn |